Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies CEO, Others Resign Following Annual Meeting

NEW YORK (GenomeWeb News) – Paul MacLeman, CEO of Australian firm Genetic Technologies, and other members of the firm's board and executive team resigned Tuesday following the firm's annual general meeting.

The resignations came after Chairman Mel Bridges and Director Huw Jones were not re-elected to the firm's board. Those two will leave the board along with Director Greg Brown, who resigned following the results of the voting even though he was re-elected. David Sparling, VP of legal and corporate development for the firm, also tendered his resignation.

GenomeWeb Daily News was unable to receive additional information and comment from Genetic Technologies by the time this article was published. However, the website of Australia's national newspaper, The Australian, reported that Genetic Technologies Founder Mervyn Jacobson had used his 29 percent stake in the firm to block the re-elections of Bridges and Jones.

"Dr. Bridges said it is regrettable that a company with the potential of GTG was unable to reach middle ground with its major shareholder," Genetic Technologies said in a statement posted on its website.

Genetic Technologies sells the BrevaGen breast cancer risk stratification test. The firm recently reported a 50 percent decline in first-quarter revenues.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.